Avacta increases placing size to GBP26 million thanks to strong demand
(Alliance News) - Avacta Group PLC on Thursday said it is increasing its placing to GBP25.7 million, "in light of the strong demand."
Read moreTue, 29th Jun 2021 08:36
(Alliance News) - Avacta Group PLC on Thursday said it is increasing its placing to GBP25.7 million, "in light of the strong demand."
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read more(Sharecast News) - Healthcare therapeutics company Avacta tumbled on Thursday after a heavily discounted placing.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Oncology drugs and diagnostics developer Avacta announced the appointment of Dr Christina Coughlin as its new head of research and development for the therapeutics division on Friday.
Read moreAvacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - Appoints Christina Coughlin as head of research and development. Coughlin, who will take up the position on February 1, has served as a non-executive director of Avacta since March 2022 and was appointed consultant in interim in September 2023. She previously served as chief executive officer of Cytoimmune Therapeutics LLC, a clinical stage biotechnology company focused on novel cancer immunotherapy products. In the new role, Coughlin will oversee clinical and pre-clinical research and development activities for the company's therapeutics division, while retaining her position on as an executive director of Avacta. The company says that Coughlin has been "pivotal" in the development strategy for its AVA6000 tumour-targeted therapy.
Read more(Sharecast News) - Oncology drugs and diagnostics specialist Avacta Group announced the appointment of Dr Simon Bennett as the chief business officer of its therapeutics division on Tuesday.
Read moreAvacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - Hires Simon Bennett as chief business officer of Therapeutics division. Says Bennett has over 26 years of commercial experience in the biopharma industry and has "worked with" various large and mid-sized companies like Bristol-Myers Squibb Co and Menarini Group.
Read more(Alliance News) - Avacta Group PLC on Wednesday celebrated strong results from its latest cancer-targeting study, which showed the release of a chemotherapy to the tumour as intended.
Read more(Sharecast News) - Oncology drugs group Avacta has announced positive results from its lead pre|CISION programme, AVA6000, which it says has the potential to be "truly remarkable".
Read moreAvacta Group PLC - Wetherby, England-based life sciences company that develops targeted oncology drugs and diagnostics - Pretax loss widens to GBP12.8 million in the six months that ended June 30 from GBP9.7 million a year before. Revenue doubles to GBP11.9 million from GBP5.5 million, but selling, general and administrative expenses near double as well, to GBP8.6 million from GBP4.7 million. Research costs are steady at GBP6.0 million. Has GBP26.0 million cash, up from GBP17.0 million a year before, though down from GBP41.8 million on December 31. Highlights success of AVA6000, a chemotherapy drug for cancer patients, in a Phase 1a clinical study. Avacta aims to complete a dose escalation safety study and provide results during the fourth quarter.
Read more(Sharecast News) - Cancer treatments and diagnostics group Avacta reported higher losses in the first half despite a doubling of revenues.
Read moreFriday 22 September | |
Ascential PLC | Half Year Results |
Ergomed PLC | Half Year Results |
First Tin PLC | Half Year Results |
t42 IoT Tracking Solutions PLC | Half Year Results |
t42 IoT Tracking Solutions PLC | Trading Statement |
Monday 25 September | |
Alphawave IP Group PLC | Half Year Results |
Devolver Digital Inc | Half Year Results |
Dialight PLC | Half Year Results |
Getech Group PLC | Half Year Results |
Ondine Biomedical Inc | Half Year Results |
Real Estate Investors PLC | Half Year Results |
SpaceandPeople PLC | Half Year Results |
Spectra Systems Corp | Half Year Results |
Transense Technologies PLC | Full Year Results |
Venture Life Group PLC | Half Year Results |
Wilmington PLC | Full Year Results |
Tuesday 26 September | |
Alliance Pharma PLC | Half Year Results |
AG Barr PLC | Half Year Results |
Animalcare Group PLC | Half Year Results |
Asos PLC | Trading Statement |
Boku Inc | Half Year Results |
Card Factory PLC | Half Year Results |
Cambridge Cognition Holdings PLC | Half Year Results |
Close Brothers Group PLC | Full Year Results |
Diaceutics PLC | Half Year Results |
DigitalBox PLC | Half Year Results |
Dillistone Group PLC | Half Year Results |
EKF Diagnostics Holdings PLC | Half Year Results |
Ferguson PLC | Full Year Results |
Finsbury Food Group PLC | Full Year Results |
IQGeo Group PLC | Half Year Results |
Learning Technologies Group PLC | Half Year Results |
LifeSafe Holdings PLC | Half Year Results |
Mission Group PLC | Half Year Results |
Mortgage Advice Bureau Holdings PLC | Half Year Results |
NAHL Group PLC | Half Year Results |
Next 15 Group PLC | Half Year Results |
Newmark Security PLC | Full Year Results |
NIOX Group PLC | Half Year Results |
Origin Enterprises PLC | Full Year Results |
PZ Cussons PLC | Full Year Results |
Safestay PLC | Half Year Results |
Smiths Group PLC | Full Year Results |
Time Finance PLC | Full Year Results |
tinyBuild Inc | Half Year Results |
Wentworth Resources PLC | Half Year Results |
Yu Group PLC | Half Year Results |
Wednesday 27 September | |
Amicorp FS (UK) PLC | Half Year Results |
Aquila European Renewables PLC | Half Year Results |
Arix Bioscience PLC | Half Year Results |
Avingtrans PLC | Full Year Results |
Bens Creek Group PLC | Full Year Results |
Biome Technologies PLC | Half Year Results |
BioPharma Credit PLC | Half Year Results |
Chapel Down Group PLC | Half Year Results |
Everyman Media Group PLC | Half Year Results |
Fadel Partners Inc | Half Year Results |
NCC Group PLC | Full Year Results |
Old Mutual Ltd | Half Year Results |
Pantheon Infrastructure PLC | Half Year Results |
Pendragon PLC | Full Year Results |
Plant Health Care PLC | Half Year Results |
Safestyle UK PLC | Half Year Results |
Saga PLC | Half Year Results |
Skillcast Group PLC | Half Year Results |
Surface Transforms PLC | Half Year Results |
Xeros Technology Group PLC | Half Year Results |
Zinc Media Group PLC | Half Year Results |
Thursday 28 September | |
Atlantic Lithium Ltd | Full Year Results |
Avacta Group PLC | Half Year Results |
Avation PLC | Full Year Results |
Celadon Pharmaceuticals PLC | Half Year Results |
Ceres Power Holdings PLC | Half Year Results |
Dar Global PLC | Half Year Results |
eEnergy Group PLC | Full Year Results |
HSS Hire Group PLC | Half Year Results |
Microlise Group PLC | Full Year Results |
Novacyt SA | Half Year Results |
Phoenix Spree Deutschland Ltd | Half Year Results |
RBG Holdings PLC | Half Year Results |
Shield Therapeutics PLC | Half Year Results |
Silver Bullet Data Services Group PLC | Half Year Results |
Trellus Health PLC | Half Year Results |
Trinity Exploration & Production PLC | Half Year Results |
XLMedia PLC | Half Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Oncology-focussed life science company Avacta Group announced a new consultancy pact with Dr Christina Coughlin on Tuesday.
Read more